101
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Epidemiology of Eye Cancer in Cali, Colombia: A 55-Year Study

ORCID Icon, , , , , & show all
Pages 374-384 | Received 31 Mar 2023, Accepted 02 Oct 2023, Published online: 17 Oct 2023

References

  • Bastola P, Koirala S, Pokhrel G, et al. A clinico-histopathological study of Orbital and Ocular Lesions; a multicenter study. J Chitwan Med Coll. 2013;3(2):40–44. doi:10.3126/jcmc.v3i2.8442.
  • Maheshwari A, Finger PT. Cancers of the eye. Cancer Metastasis Rev. 2018;37(4):677–690. doi:10.1007/s10555-018-9762-9.
  • National Cancer Institute. Seer*stat software, version 8.3.5. Surveillance, epidemiology, and end results program, National Cancer Institute; 2019. Accessed January 17, 2020. www.seer.cancer.gov
  • Aronow ME, Topham AK, Singh AD. Uveal Melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013). Ocul Oncol Pathol. 2018;4(3):145–151. doi:10.1159/000480640.
  • Scott JF, Vyas R, Galvin J, et al. Primary bilateral uveal melanoma: a population-based study and systematic review. Clin Exp Ophthalmol. 2018;46(5):502–510. doi:10.1111/ceo.13129.
  • Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011;118(9):1881–1885. doi:10.1016/j.ophtha.2011.01.040
  • Verdijk RM. Lymphoproliferative tumors of the ocular adnexa. Asia-Pacific J Ophthalmol. 2017;6:132–142.
  • Desai A, Joag MG, Lekakis L, et al. Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study. Blood. 2017;129(3):324–332. doi:10.1182/blood-2016-05-714584.
  • Cancer Research UK. Achieving world class cancer outcomes: strategy 2015 -2020. 2020.
  • Parkin D M, Stiller CA, Draper G J, et al. The international incidence of childhood cancer. Int J Cancer. 1988;42(4): 511–520. doi:10.1002/ijc.2910420408
  • Retinoblastoma Study Group G, Fabian ID, Abdallah E, et al. Global Retinoblastoma Presentation and analysis by National Income Level [published correction appears in JAMA oncol. 2020 Nov 1;6(11): 1815]. JAMA Oncol. 2020;6(5):685–695. doi:10.1001/jamaoncol.2019.6716.
  • Rishi P, Dhami A, Biswas J. Biopsy techniques for intraocular tumors. Indian, J Ophthalmol. 2016;64(6):415–421. doi:10.4103/0301-4738.187652.
  • Rao R, Saeed HN, Chodosh J. Advances in imaging of ocular surface tumors. Int Ophthalmol Clin. 2017;57(4):21–29. doi:10.1097/IIO.0000000000000187.
  • Lingam G. Options for management of intra ocular tumors. Indian, J Ophthalmol. 2015;63(3):204–210. doi:10.4103/0301-4738.156913.
  • Francis JH, Roosipu N, Levin AM, et al. Current treatment of bilateral retinoblastoma: the impact of intraarterial and intravitreous chemotherapy. Neoplasia (United States. Neoplasia. 2018;20(8):757–763. doi:10.1016/j.neo.2018.05.007.
  • García LS, Bravo LE, Collazos P, et al. Cali cancer registry methods. Colomb Med. 2018;49(1):109–120. doi:10.25100/cm.v49i1.3853.
  • Departamento Administrativo Nacional de Estadística. Estimaciones y proyecciones de poblacion [Internet]. DANE. 2021 [cited 2021 May 30]. p. 1–9. Available from: https://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/proyecciones-de-poblacion.
  • Departamento Administrativo de Planeación Municipal. Documentos de Cali en Cifras. 2020. Available: https://www.cali.gov.co/planeacion/publicaciones/137803/documents-cali-en-cifras/
  • World Health Organization. ICD·O: International Classification of Diseases for Oncology. Geneva: World Health Organization. World Heal Organ; 1976.
  • Cheng CY, Hsu WM. Incidence of eye cancer in Taiwan: an 18-year review. Eye. 2004;18(2):152–158. doi:10.1038/sj.eye.6700619.
  • Mahoney MC, Burnett WS, Majerovics A, et al. The epidemiology of ophthalmic malignancies in New York State. Ophthalmology. 1990;97(9):1143–1147. doi:10.1016/S0161-6420(90)32445-4.
  • Lee SB, Au Eong KG, Saw SM, et al. Eye cancer incidence in Singapore. Br J Ophthalmol. 2000;84(7):767–770. doi:10.1136/bjo.84.7.767.
  • Instituto Nacional de Cancerología. Boletin Epidemiológico INC. No 9 Año 2016 Publicación Anu Bogotá. ISSN 2145-0196. DC: Colomb; 2016.
  • Lin HN, Gu XY, Zhang SW, et al. Analysis on incidence and mean age at diagnosis for global cancer. Zhonghua Zhong Liu Za Zhi. 2018;40(7):543–549. doi:10.3760/cma.j.issn.0253-3766.2018.07.012.
  • National Cancer Institute Bethesda. Program SR. National Cancer Institute SEER* Stat software. 2015.
  • Kim H, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–351. doi:10.1002/(SICI)1097-0258(20000215)19:3<335:AID-SIM336>3.0.CO;2-Z.
  • Administradora de los Recursos del Sistema General de Seguridad Social en Salud -ADRES. Base de Datos Unica de Afiliados - BDUA [Internet]. 2021 [cited 2021 Oct 9]. Available from: https://aplicaciones.adres.gov.co/bdua_internet/Pages/ConsultarAfiliadoWeb.aspx
  • Registraduría Nacional del Estado Civil [Internet]. 2021 [cited 2021 Oct 9]. Available from: https://wsp.registraduria.gov.co/censo/consultar/.
  • Perme MP, Stare J, Estève J. On estimation in relative survival. Biometrics. 2012;68(1):113–120. doi:10.1111/j.1541-0420.2011.01640.x.
  • Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977–1010. doi:10.1016/S0140-6736(14)62038-9.
  • Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075. doi:10.1016/S0140-6736(17)33326-3.
  • Bray F, Znaor A, Cueva P et al. Planing and developing population-base cancer registration in low- and - middle- income setting. In: editor Müller K. IARC Technical Publications N. 43. International Agency for Research on Cancer. Lyon: (Fr); 2014:1–49.
  • Cendales R, Pardo C. Quality of death certification in Colombia. Colomb Med. 2018;49(1):121–127. doi:10.25100/cm.v49i1.3155.
  • International Agency for Research on Cancer, World Health Organization. Registries EN of C, European commission. In: Tyczynski JE, Démaret E, Parkin DM, eds. Standards and Guidelines for Cancer Registration in Europe: The ENCR Recommendations [Internet]. Vol. 1, Lyon:2003:110. Available from: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Technical-Publications/Standards-And-Guidelines-For-Cancer-Registration-In-Europe-2003
  • Symanzik C, John SM. Sun protection and occupation: Current developments and perspectives for prevention of occupational skin cancer. Front Publ Health, 2022 Dec 23;10:1110158. doi:10.3389/fpubh.2022.1110158. PMID: 36620257; PMCID: PMC9816330.
  • Luna L. COLOMBIAN VIOLENT CONFLICT: a HISTORICAL PERSPECTIVE. Inter J World Peace. 2019 Accessed 17 July 2023;36(4):53–84. https://www.jstor.org/stable/26885039.
  • Bennettand TJ, Barry CJ. Ophthalmic imaging today: an ophthalmic photographer’s viewpoint – a review. Clin Exp Ophthalmol. 2009;37:2–13. doi:10.1111/j.1442-9071.2008.01812.x.
  • Nayman T, Bostan C, Logan P, et al. Uveal melanoma risk factors: a systematic review of meta-analyses. Curr Eye Res. 2017 Aug;42(8):1085–1093. doi:10.1080/02713683.2017.1297997. Epub 2017 May 11. PMID: 28494168.
  • Howlader N, Noone AM, Krapcho M, eds. SEER Cancer Statistics Review, 1975-2017, National Cancer Institute. Bethesda, MD. 2020. https://seer.cancer.gov/csr/1975_2017/ based on November 2019 SEER data submission, posted to the SEER web site, April 2020
  • Valasapalli S, Guddati AK. Nation-Wide Trends in Incidence-Based Mortality of Patients with ocular melanoma in USA: 2000 to 2018. Int J Gen Med, 2021 Aug 5;14:4171–4176. doi:10.2147/IJGM.S299144. PMID: 34385837; PMCID: PMC8354021.
  • Smidt-Nielsen I, Bagger M, Heegaard S, et al. Posterior uveal melanoma incidence and survival by AJCC tumour size in a 70-year nationwide cohort. Acta Ophthalmol. 2021 Dec;99(8):e1474–e1482. doi:10.1111/aos.14847. Epub 2021 Mar 18. PMID: 33738986.
  • Gündüz AK, Mirzayev I, Temel E, et al. A 20-year audit of retinoblastoma treatment outcomes. Eye (Lond). 2020 Oct;34(10):1916–1924. doi:10.1038/s41433-020-0898-9. Epub 2020 May 6. Erratum in: Eye (Lond). 2020 Aug 5;: PMID: 32376976; PMCID: PMC7608123.
  • Pulumati A, Pulumati A, Dwarakanath BS, et al. Technological advancements in cancer diagnostics: improvements and limitations. Cancer Rep (Hoboken). 2023 Feb;6(2):e1764. doi:10.1002/cnr2.1764. Epub 2023 Jan 6. PMID: 36607830; PMCID: PMC9940009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.